L. Chrones

发表

Characterizing Primary Care for Patients With Major Depressive Disorder Using Electronic Health Records of a US-Based Healthcare Provider.

M. Gionfriddo, M. Touya, Sharon Larson, 2021, Journal of affective disorders.

Incremental burden of comorbid major depressive disorder in patients with type 2 diabetes or cardiovascular disease: a retrospective claims analysis

M. Touya, M. Polson, A. Kangethe, 2021, BMC Health Services Research.

The safety and tolerability of vortioxetine: Analysis of data from randomized placebo-controlled trials and open-label extension studies

D. Baldwin, G. Nomikos, I. Florea, 2016, Journal of psychopharmacology.

Adherence and persistence among patients with major depressive disorder enrolled in the vortioxetine tAccess Patient Support Program

J. Manjelievskaia, M. Touya, M. McCue, 2021, Current medical research and opinion.

Incremental burden of relapse in patients with major depressive disorder: a real-world, retrospective cohort study using claims data

M. Touya, M. Polson, A. Kangethe, 2022, BMC Psychiatry.

Safety and tolerability of vortioxetine (15 and 20 mg) in patients with major depressive disorder: results of an open-label, flexible-dose, 52-week extension study

Serena T. Chan, L. Harper, A. Mahableshwarkar, 2015, International clinical psychopharmacology.

A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor

J. Xie, T. Macek, M. Tsai, 2016, Psychopharmacology.

Effect of Vortioxetine vs. Escitalopram on Sexual Functioning in Adults with Well-Treated Major Depressive Disorder Experiencing SSRI-Induced Sexual Dysfunction.

A. Clayton, Yinzhong Chen, A. Mahableshwarkar, 2015, The journal of sexual medicine.

Effectiveness of vortioxetine for major depressive disorder in real-world clinical practice: US cohort results from the global RELIEVE study

G. Mattingly, K. Simonsen, D. Lawrence, 2023, Frontiers in Psychiatry.

Design and Implementation of a Digitally Enabled Care Pathway to Improve Management of Depression in a Large Health Care System: Protocol for the Implementation of a Patient Care Platform

B. Fehnert, D. Kemp, R. Khatib, 2023, JMIR research protocols.

An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation Study

Nelson B Rodrigues, R. McIntyre, B. Fehnert, 2022, JMIR mental health.

User-Centered Design of a Digitally Enabled Care Pathway in a Large Health System: Qualitative Interview Study

B. Fehnert, R. Khatib, James King, 2023, JMIR human factors.

A phase 1 study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of TAK-063, a selective PDE10A inhibitor

T. Macek, M. Tsai, H. Gevorkyan, 2016, Psychopharmacology.

Design of a real-world, prospective, longitudinal, observational study to compare vortioxetine with other standard of care antidepressant treatments in patients with major depressive disorder: a PatientsLikeMe survey

R. McIntyre, S. Parikh, M. Opler, 2023, BMC Psychiatry.

Real-world clinical outcomes and treatment patterns in patients with MDD treated with vortioxetine: a retrospective study

D. Lawrence, L. Chrones, S. Sarkey, 2023, BMC psychiatry.

Antidepressant Use and Treatment-Emergent Sexual Dysfunction Among Patients With Major Depressive Disorder: Results From an Internet-Based Survey Study

M. Touya, L. Chrones, Judith J. Stephenson, 2024, Journal of Affective Disorders Reports.

Longitudinal study to assess antidepressant treatment patterns and outcomes in individuals with depression in the general population.

A. Krystal, M. Ohayon, M. McCue, 2022, Journal of affective disorders.